PACS Group (NYSE:PACS) Research Coverage Started at Truist Financial

Equities research analysts at Truist Financial initiated coverage on shares of PACS Group (NYSE:PACS) in a report issued on Monday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $32.00 price target on the stock. Truist Financial’s price objective indicates a potential upside of 28.05% from the company’s current price.

Separately, Royal Bank of Canada assumed coverage on PACS Group in a research note on Monday. They set an “outperform” rating and a $30.00 price objective for the company. Six equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $30.50.

PACS Group Stock Up 0.2 %

Shares of NYSE:PACS opened at $24.99 on Monday. PACS Group has a 12-month low of $22.61 and a 12-month high of $25.72.

Insiders Place Their Bets

In other PACS Group news, CEO Jason Hulse Murray sold 1,607,142 shares of PACS Group stock in a transaction on Monday, April 15th. The stock was sold at an average price of $21.00, for a total value of $33,749,982.00. Following the completion of the sale, the chief executive officer now owns 62,754,551 shares of the company’s stock, valued at approximately $1,317,845,571. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

PACS Group Company Profile

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.